Detection of Heterogeneity of Borrelia burgdorferi in
Abilities to detect heterogeneity of ospC genotypes of the Lyme disease spirochete Borrelia burgdorferi in the tick vector by in vitro culture (IVC) and direct PCR (dPCR) were compared. IVC failed to detect one-third of the ospC genotypes detected by dPCR. Among IVC results, common ospC genotypes were overrepresented while occurrence of rare genotypes was underestimated.
A bility to culture Borrelia burgdorferi has been essential for clinical, epidemiological, and pathogenicity studies of B. burgdorferi (1) . Various culture medium formulations for Borrelia growth have been widely used to isolate B. burgdorferi from ticks, hosts, and clinical samples (2-4). More recently, culture-independent means of Borrelia detection, usually involving PCR, have become the gold standard (5) . One widely used genetic marker for detection of B. burgdorferi is the gene encoding outer surface protein C (ospC). The ospC gene encodes an important major surface protein that has proven useful for discriminating several genotypes (6) (7) (8) (9) .
A comparison of B. burgdorferi strains cultured from ticks with those cultured from clinical samples has led to conclusions that a limited set of ospC genotypes (A, B, I, and K) are invasive and cause systemic disease while the others are limited to ticks or persist as localized infections (8, 10) . While several investigators have reported a cultivation effect of B. burgdorferi, all results are based on clinical samples and/or conserved genetic markers. In this study, we compared performances of direct PCR (dPCR) and in vitro cultivation (IVC) to detect 17 distinct Borrelia burgdorferi ospC genotypes from tick specimens.
A total of 926 adult deer ticks were surface sterilized in providone-iodine and then rinsed in 70% EtOH. Ticks in one treatment group (n ϭ 420) were bisected by a dorsoventral medial cut, and one half of the ticks were placed directly into BSK-H medium (Sigma-Aldrich, St. Louis, MO) while the other half were used for DNA extraction. Ticks in a second treatment group (n ϭ 506) were dissected, and gut contents were placed in 1.5 ml BSK-H medium; the remainder of the tick body was used in DNA extraction as described above. All cultures were incubated at 34°C and checked biweekly for 4 weeks by dark-field microscopy.
After 4 weeks, 25 l of each culture was transferred to a 96-well plate containing 75 l H 2 O, heated to 95°C for 10 min, and centrifuged at 6,000 ϫ g for 10 min, and the resulting supernatant was used as a template for PCR. DNA extraction was performed using the Epicentre Master Complete DNA and RNA purification kits (Epicentre Technologies, Madison, WI). PCR conditions for ospC and the reverse line blotting technique were as described previously (7, 11) . In addition to the 15 published probes, two new ospC probes were used in this study. We named these type-V (5=-GAG CCG CTT GAG CAG TTA AAC CAT TTG CAC C-3=) and type-W (5=-TCG TTT CGA TTT GCT TCT ACA CCC-3=).
dPCR of ticks detected a higher overall infection rate (61.9%) than IVC (34.3%) ( 2 ϭ 140.64; degrees of freedom [df] ϭ 1; P Ͻ 0.0001) ( Table 1) . Moreover, ospC samples positive by IVC were almost entirely a subset of positive samples from dPCR. Of all 573 ospC-positive samples, 52.8% were positive by both methods, 45.5% were positive by dPCR (dPCRϩ)/negative by IVC (IVCϪ), and only 1.7% were dPCRϪ/IVCϩ. Estimated infection prevalence from cultures was also highly dependent on different dissection methods. The rate of successful detection by midgut dissection (49.2%) was significantly higher a Numbers of positive samples by dPCR and by IVC were significantly different (P Ͻ 0.0001). b Numbers of positive samples from female adults and male adults were not significantly different (P Ͼ 0.4030). The positive rate of midgut culture was significantly higher than the rate for half-tick culture ( 2 ϭ 245.036; df ϭ 1; P Ͻ 0.0001).
than the rate by whole-body bisection (16.4%) ( 2 ϭ 245.04; df ϭ 1; P Ͻ 0.0001).
Ticks harboring multiple ospC genotypes were detected by both dPCR and IVC; however, genotype diversity detected was greater for dPCR than for IVC ( 2 ϭ 10.78; df ϭ 1; P Ͻ 0.001). Of 573 ticks positive by dPCR, 65.3% had two or more ospC genotypes, while among the 318 IVC-positive ticks, 44.9% of cultures were multiply infected. The average numbers of ospC genotype infections were 2.54 and 2.05 for dPCR and IVC, respectively.
Overall commonness of ospC genotypes differed widely. Genotypes A, E, I, and K were high-frequency genotypes (Ͼ10%), together comprising 58.6% and 69.0% of the total genotypes detected by dPCR and IVC, respectively. Genotypes F, G, N, and V were intermediate-frequency genotypes (5 to 10%). The remaining 10 genotypes (B, D, H, J, L, M, O, T, U, and W) were either detected at low frequency (Ͻ5%) or absent.
To determine the difference in recovery rates of particular ospC genotypes when comparing dPCR and IVC, we conservatively restricted our analysis to the subset (n ϭ 308) of ticks that tested positive by both methods. Of the 308 pairwise positives, 174 (56.5%) had identical ospC results while 105 (34.1%) showed IVC genotypes as a subset of dPCR genotypes. Only 15 (4.5%) showed the dPCR genotypes to be a subset of IVC genotypes. Fourteen (4.9%) paired results were mismatched such that both dPCR and IVC detected one or more unique genotypes absent from the genotype results for the other. More than one-third of positive samples had fewer ospC genotypes per tick by IVC.
We defined the quantity D, our estimate of the difference between recovery rates for a particular genotype, with F c Ϫ F t , where F t is the fraction of times the genotype was detected by dPCR and F c is the frequency found by IVC. When IVC and dPCR are equally likely to detect a given genotype, the D value will be zero. A bootstrap sampling routine that created 10,000 new data sets was used to generate 95% confidence intervals for each D (12) . Genotypespecific differences in recovery rates for which confidence intervals did not overlap zero were deemed statistically significant. Statistical analyses were carried out using the chi-square test. The D values of nine genotypes were statistically significantly different from zero (Fig. 1) . Genotypes A, E, and K were more often detected by IVC, while genotypes B, F, J, M, N, and V were more often detected in dPCR. We conclude that the bias in detection is not equivalent across all ospC genotypes.
Differential detection of genotype frequencies by dPCR and IVC may be merely a function of starting frequencies within individual ticks. We do not know the frequencies of genotypes within individual ticks, but it might be assumed that frequencies among ticks reflect frequencies within ticks. Therefore, genotypes that are rare among all ticks would also be infrequent in individual ticks and, hence, more likely to fall below the detection threshold. Ability to detect a given Borrelia genotype by IVC is contingent upon having a sufficient number of spirochetes to establish in culture. High-frequency genotypes would be more often detected than low-frequency genotypes. Genotypes A, E, and K were high-frequency genotypes, making up 48.8% and 59.3% of the total genotypes detected by dPCR and IVC, respectively. These high-frequency genotypes, A, E, and K, were more likely to be detected by IVC, whereas the low-frequency genotypes B, F, J, M, N, and V were less often detected by IVC (Fig. 1) .
Two of these high-frequency genotypes (A and K) have been associated with systemic human disease (8) . In suburban New York City, genotypes A and K were detected among 56.8% of Lyme disease cases (10) . This has led some to conclude that these genotypes have greater propensity for invasion of mammalian tissues. However, this may not be the case. Since these genotypes are also most abundant among ticks, their higher frequency among Lyme cases may well be attributed to their greater prevalence in human-biting ticks. More work is needed to discern mechanisms that drive ospC genotype frequencies among ticks to better understand what might be driving population dynamics of Borrelia in human patients.
